Skip to main content
. 2022 Sep 3;12(9):2150. doi: 10.3390/diagnostics12092150

Figure 3.

Figure 3

BChE activity in critically ill COVID-19 patients who did not require vvECMO therapy during the 28-day observation time compared to patients who required vvECMO therapy. Scatterplots represent the BChE activity in critically ill COVID-19 patients who did not require vvECMO therapy during the observation period of 28 days (n = 12) compared to patients with vvECMO on day 1 (1.713 U/L (971–1.925) vs. patients on vvECMO support (n = 39): 1.264 U/L (916–1.456)); (A) and on day 3 after ICU admission (1.447 U/L (1.125–1.754) vs. patients on vvECMO support (n = 40): 1.073 U/L (735–1.307)); (B).* p < 0.05 Mann–Whitney U-Test.